Clinical Trials
28 trialsLong-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
Nanjing University
Sleep State in Lung Cancer: A Retrospective Analysis
Shanghai Zhongshan Hospital
Lung Cancer Mutation Consortium Protocol
University of Colorado, Denver
Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)
Fudan University
Cios Mobile 3D Spin for Robotic Bronchoscopy
Mayo Clinic
HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008)
Fudan University
Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011)
Fudan University
Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants
National Taiwan University Hospital
Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy
Post Graduate Institute of Medical Education and Research, Chandigarh
Lung Nodule Prospective Database
Singapore General Hospital
Radiomics-based Prediction Model of Tumor Spread Through Air Space in Lung Adenocarcinoma
University of Roma La Sapienza
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Whole-Exome Sequencing (WES) of Cancer Patients
Dana-Farber Cancer Institute
Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
IRCCS San Raffaele
An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Mayo Clinic
Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital Center
Central Hospital, Nancy, France
The Detection of EGFR Mutations in Liquid Based Cytology Samples
Royal Cornwall Hospitals Trust
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
Geneplus-Beijing Co. Ltd.
RMBPN
Maastricht University
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
Hoffmann-La Roche
Study of Tumor Samples From Patients With Lung Cancer
Alliance for Clinical Trials in Oncology
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
Eastern Cooperative Oncology Group
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Eastern Cooperative Oncology Group
Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030
Alliance for Clinical Trials in Oncology
IDENTIFY
AstraZeneca